Aortic Dimensions in Patients With Fabry Disease

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06956573

Acronym

DATA-Fab

Enrollment

200

Registered

2025-05-04

Start date

2025-05-02

Completion date

2026-05-02

Last updated

2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry Disease

Brief summary

We will conduct a retrospective study aiming to define the characteristics, determinants, and progression of ascending aortic dilatation in adults with Fabry disease, using echocardiography and/or cardiac MRI

Interventions

OTHERaorta imaging

Retrospective analysis of imaging data (echocardiography and/or cardiac MRI) in adult patients with Fabry disease to assess ascending aortic diameters.

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

a adult patients with genetically confirmed Fabry disease must be able to signed informed consent for participation in the study

Exclusion criteria

Patient refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score.	At baseline

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026